E-cadherin Induces Mesenchymal-to-epithelial Transition in Human Ovarian Surface Epithelium
Overview
Affiliations
Ovarian carcinomas are thought to arise in the ovarian surface epithelium (OSE). Although this tissue forms a simple epithelial covering on the ovarian surface, OSE cells exhibit some mesenchymal characteristics and contain little or no E-cadherin. However, E-cadherin is present in metaplastic OSE cells that resemble the more complex epithelia of the oviduct, endometrium and endocervix, and in primary epithelial ovarian carcinomas. To determine whether E-cadherin was a cause or consequence of OSE metaplasia, we expressed this cell-adhesion molecule in simian virus 40-immortalized OSE cells. In these cells the exogenous E-cadherin, all three catenins, and F-actin localized at sites of cell-cell contact, indicating the formation of functional adherens junctions. Unlike the parent OSE cell line, which had undergone a typical mesenchymal transformation in culture, E-cadherin-expressing cells contained cytokeratins and the tight-junction protein occludin. They also formed cobblestone monolayers in two-dimensional culture and simple epithelia in three-dimensional culture that produced CA125 and shed it into the culture medium. CA125 is a normal epithelial-differentiation product of the oviduct, endometrium, and endocervix, but not of normal OSE. It is also a tumor antigen that is produced by ovarian neoplasms and by metaplastic OSE. Thus, E-cadherin restored some normal characteristics of OSE, such as keratin, and it also induced epithelial-differentiation markers associated with weakly preneoplastic, metaplastic OSE and OSE-derived primary carcinomas. The results suggest an unexpected role for E-cadherin in ovarian neoplastic progression.
Exploring the characteristics of immortalized human ovarian surface epithelial cell lines.
Shin H, Yang W, Kim J, Chang H, Yoo J, Choi W Heliyon. 2025; 11(4):e42539.
PMID: 40034272 PMC: 11874562. DOI: 10.1016/j.heliyon.2025.e42539.
The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease.
Peng Q, Shan D, Cui K, Li K, Zhu B, Wu H Cells. 2022; 11(11).
PMID: 35681530 PMC: 9180466. DOI: 10.3390/cells11111834.
Garrido M, Vallejos C, Girardi S, Gabler F, Selman A, Lopez F Int J Mol Sci. 2022; 23(4).
PMID: 35216240 PMC: 8877415. DOI: 10.3390/ijms23042124.
Ramos-Garcia P, Gonzalez-Moles M Cancers (Basel). 2022; 14(3).
PMID: 35158747 PMC: 8833491. DOI: 10.3390/cancers14030479.
Xu J, Liu F, Liu S, Xie L, Li J, Ma Y J Oncol. 2021; 2021:6852867.
PMID: 34912456 PMC: 8668291. DOI: 10.1155/2021/6852867.